Author

Fernando Gomollón

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management

Fernando Gomollón  et al.

SAFETY AND LONG-TERM PERSISTENCE OF BIOLOGICAL TREATMENTS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE. DIFFERENCES BETWEEN WOMEN AND MEN: SEXEII STUDY OF ENEIDA
SAFETY AND LONG-TERM PERSISTENCE OF BIOLOGICAL TREATMENTS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE. DIFFERENCES BETWEEN WOMEN AND MEN: SEXEII STUDY OF ENEIDA

USTEKINUMAB AND VEDOLIZUMAB AS FIRST-LINE BIOLOGICAL THERAPY FOR INFLAMMATORY BOWEL DISEASE IN CLINICAL PRACTICE. A MULTICENTER STUDY BASED ON THE ENEIDA REGISTRY
USTEKINUMAB AND VEDOLIZUMAB AS FIRST-LINE BIOLOGICAL THERAPY FOR INFLAMMATORY BOWEL DISEASE IN CLINICAL PRACTICE. A MULTICENTER STUDY BASED ON THE ENEIDA REGISTRY

Fernando Gomollón  et al.

PATTERNS OF CORTICOSTEROID EXPOSURE AND EXCESS IN INFLAMMATORY BOWEL DISEASE: RESULTS FROM THE DETERMINANTS, INCIDENCE AND CONSEQUENCES OF CORTICOSTEROID EXCESS (DICE) ONLINE MONITORING TOOL
PATTERNS OF CORTICOSTEROID EXPOSURE AND EXCESS IN INFLAMMATORY BOWEL DISEASE: RESULTS FROM THE DETERMINANTS, INCIDENCE AND CONSEQUENCES OF CORTICOSTEROID EXCESS (DICE) ONLINE MONITORING TOOL

Fernando Gomollón  et al.

European Consensus on the Diagnosis and Management of Iron Deficiency and Anaemia in Inflammatory Bowel Diseases
European Consensus on the Diagnosis and Management of Iron Deficiency and Anaemia in Inflammatory Bowel Diseases

Fernando Gomollón  et al.

BEING YOUNG AND WOMEN ARE RISK FACTORS FOR MALNUTRITION ACCORDING TO GLIM CRITERIA IN INFLAMMATORY BOWEL DISEASE OUTPATIENS
BEING YOUNG AND WOMEN ARE RISK FACTORS FOR MALNUTRITION ACCORDING TO GLIM CRITERIA IN INFLAMMATORY BOWEL DISEASE OUTPATIENS

Fernando Gomollón  et al.

INCREASED PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN LEAN INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASE
INCREASED PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN LEAN INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASE

Fernando Gomollón  et al.

NAFLD AND LIVER FIBROSIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A CASE-CONTROL STUDY
NAFLD AND LIVER FIBROSIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A CASE-CONTROL STUDY

Fernando Gomollón  et al.

PREDICTORS OF ANTI-TNF TREATMENT FAILURE IN INFLAMMATORY BOWEL DISEASE PATIENTS NAÏVE TO BIOLOGIC DRUGS: A 20-YEAR REAL WORLD STUDY
PREDICTORS OF ANTI-TNF TREATMENT FAILURE IN INFLAMMATORY BOWEL DISEASE PATIENTS NAÏVE TO BIOLOGIC DRUGS: A 20-YEAR REAL WORLD STUDY

Fernando Gomollón  et al.

NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY MEASURE OF PROTEIN GLYCOSILATION IS A BIOMARKER OF ACTIVITY AND METABOLIC COMPLICATIONS IN INFLAMMATORY BOWEL DISEASE
NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY MEASURE OF PROTEIN GLYCOSILATION IS A BIOMARKER OF ACTIVITY AND METABOLIC COMPLICATIONS IN INFLAMMATORY BOWEL DISEASE

Fernando Gomollón  et al.

METABOLIC ASSOCIATED LIVER DISEASE AND SEX AS KEY FACTORS OF CARDIOVASCULAR RISK IN INFLAMMATORY BOWEL DISEASE
METABOLIC ASSOCIATED LIVER DISEASE AND SEX AS KEY FACTORS OF CARDIOVASCULAR RISK IN INFLAMMATORY BOWEL DISEASE

Fernando Gomollón  et al.

ACCELERATED OR ESCALATED INDUCTION REGIMENS OF INFLIXIMAB FOR STEROID-REFRACTORY ACUTE SEVERE ULCERATIVE COLITIS IN CLINICAL PRACTICE: DATA FORM THE ENEIDA REGISTRY
ACCELERATED OR ESCALATED INDUCTION REGIMENS OF INFLIXIMAB FOR STEROID-REFRACTORY ACUTE SEVERE ULCERATIVE COLITIS IN CLINICAL PRACTICE: DATA FORM THE ENEIDA REGISTRY

Fernando Gomollón  et al.

MANAGEMENT AND OUTCOME OF POSTOPERATIVE CROHN’S DISEASE IN THE ELDERLY AS COMPARED TO YOUNG ADULTS: DATA FROM ENEIDA REGISTRY
MANAGEMENT AND OUTCOME OF POSTOPERATIVE CROHN’S DISEASE IN THE ELDERLY AS COMPARED TO YOUNG ADULTS: DATA FROM ENEIDA REGISTRY

Fernando Gomollón  et al.

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 2: Surgical Management and Special Situations
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 2: Surgical Management and Special Situations

Fernando Gomollón  et al.

ECCO Guidelines on Therapeutics in Crohn's Disease: medical treatment
ECCO Guidelines on Therapeutics in Crohn's Disease: medical treatment

Fernando Gomollón  et al.

EFFECTIVENESS AND SAFETY OF USTEKINUMAB IN ULCERATIVE COLITIS: REAL WORLD EVIDENCE FROM ENEIDA REGISTRY
EFFECTIVENESS AND SAFETY OF USTEKINUMAB IN ULCERATIVE COLITIS: REAL WORLD EVIDENCE FROM ENEIDA REGISTRY

Fernando Gomollón  et al.

LONG-TERM EVOLUTION AFTER ANTI-TNF DRUG DISCONTINUATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
LONG-TERM EVOLUTION AFTER ANTI-TNF DRUG DISCONTINUATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Fernando Gomollón  et al.

COMPARISON OF THE EFFICACY OF A SECOND INTRAVENOUS OR SUBCUTANEOUS ANTI-TNF IN THE TREATMENT OF ULCERATIVE COLITIS. REAL-WORLD DATA FROM THE ENEIDA REGISTRY
COMPARISON OF THE EFFICACY OF A SECOND INTRAVENOUS OR SUBCUTANEOUS ANTI-TNF IN THE TREATMENT OF ULCERATIVE COLITIS. REAL-WORLD DATA FROM THE ENEIDA REGISTRY

Fernando Gomollón  et al.

EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB AND USTEKINUMAB THERAPY FOR COMPLEX PERIANAL FISTULA IN CROHN’S DISEASE: THE HEAL STUDY
EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB AND USTEKINUMAB THERAPY FOR COMPLEX PERIANAL FISTULA IN CROHN’S DISEASE: THE HEAL STUDY

Fernando Gomollón  et al.

MANAGEMENT OF PATIENTS NEWLY DIAGNOSED WITH INFLAMMATORY BOWEL DISEASE BASED ON HOSPITAL CHARACTERISTICS: RESULTS FROM THE NATIONWIDE EPIDEMIBD STUDY OF GETECCU
MANAGEMENT OF PATIENTS NEWLY DIAGNOSED WITH INFLAMMATORY BOWEL DISEASE BASED ON HOSPITAL CHARACTERISTICS: RESULTS FROM THE NATIONWIDE EPIDEMIBD STUDY OF GETECCU

Fernando Gomollón  et al.

Item 1 - 20 / 26
1
2